It is without a doubt that the creation of Teflaro®, followed closely by the FDA approval for pediatric patients last year May, was an enormous milestone for Allergan as a company and for our pharmaceutical industry as a whole. However, I believe that the recent announcement of the 550% price upsurge has truly crossed our ethical boundaries even if such a choice was FDA-approved. Referring back to one of your comments made during our conference this morning, you stated that we must not overlook the uniqueness of Teflaro® in its lightly-saturated market. Even though I well agree with you that Teflaro® currently stands out as one of the scarce drug prescriptions that can cure hypersensitive skin bacteria, it is still abusive for Allergan to adopt such an …show more content…
It is this scheme that formulated the cruel hidden assumption in our industry: if a disease-curing prescription has been introduced to the public, only the wealthier population has priority access due to the astronomical prices. In turn, the low-income patients in impoverished demographics then become our front-line stakeholders who cannot afford this life-saving medicine. Couldn’t we, instead, offer a reasonable and consistent Teflaro® price by cutting back on redundant marketing costs? Couldn't we spare the cost for pediatric patients in developing countries by only cutting 12% of our profit margin? Couldn't we consider lowering the price for poorer tropical countries with higher morbidity rates, such as Nigeria and Gran Chaco, in order to bridge this gap? In my opinion, Allergan as a multibillion-dollar company, should have the most elementary moral obligation to sacrifice a slim of our profit and push towards higher levels of accessibility of Teflaro® to a wider outreach of
Click here to unlock this and over one million essaysShow More
I do agree that companies who create such products that easily cause harm to people should have some sort of action taken against their use but to that extent, I say that the companies also have to specify how much to use and when the consumption of their products becomes too much. However, the precedences for more positive descriptions of that side of the topic are a lot more complicated to explain and as such my view starts to hit a wall and I will now talk about how I disagree with Coffman 's claims. First off, Coffman makes it seem that the companies who produce legal but harmful products, which in its own right can be taken multiple ways, should pay settlements for the problems caused by their products. The problem with claims like this is that when a company makes a product they have normally created it for a specific purpose and have set in place guidelines to prevent potential harm, an example of a type of product like this would be aspirin which is commonly used as a pain reliever in the form of pills but can cause harm if too many are
A doctor should always take into consideration what is best for their patients without being influenced by anyone. In Stephanie Saul’s article “Drug Makers Pay for Lunch as they Pitch” she discusses how pharmaceutical companies use free lunches as an incentive to influence Doctors to prescribe their brand drugs. Many see this situation of pharmaceutical companies purchasing meals for a Doctor’s entire office as not having any effect on the doctor’s decision to prescribe their brand. The reality is that these free lunches do influence a doctor to prescribe a certain brand drug when writing a patient’s prescription. A doctor should consider what is the best option for a patient something that is affordable and if the case is that a name brand drug is the best option it should not be influenced by the pharmaceutical company in any way.
A new oral pharmaceutical drug for type- two diabetes had been approved for clinical use, it was called Compound 17392. Marketing companies instantly wanted to have prescribers adopt and sell the product and researchers wanted to further investigate previous reports of liver toxicity in patients. Now since paying patients to try new pharmaceutical drugs was an issue due to it appearing to interfere with clinical judgement and upholding the duty to do what is best for the patient, a new idea of furthering research for the drug came into play. The idea included recruiting a group of physicians who were in the top ten percent of prescribers for type-two diabetes. Following regulations put in place by researchers, these physicians were to enter eligible patients into the trial for Compound
Evidently everything that took place at Willowbrook was extremely unethical all around. All ten of the principles in the ATRA code of ethics were violated. Willowbrook is a perfect example of how ethics change over time. Even though today you hear stories about abuse and neglect that takes place in nursing homes this type of treatment and this amount of widespread neglect would never happen today. Today there are strict protocols and guidelines in every facility that as a professional you are required to follow.
This question represents at least half of the medical community, and makes people question the intended and unintended consequences in a profit - driven health care system, the supposition of quality health today, and whether they
Many believe that the FDA has financial reasons for allowing a drug to be on the market. In 2006, a study found that” in 22% of advisory board meetings, more than half the members had direct financial in the companies whose medial products they evaluated or their rivals”. The FDA’s advisory boards should not be able to vote on companies that they have financial ties to. The FDA says they do the best they can to create an unbiased board, but it is difficult to find “top medical experts with no ties” to pharmaceutical companies. Since a number of people have complained about this, Congress decided to make the FDA cut twenty-five percent of the advisory board that has financial ties with the pharmaceutical company being evaluated over the next five years.
James R. Baker, MD and chief medical officer of Food Allergy Research & Education (FARE), writing an article for the STAT Magazine, discloses information regarding the pharmaceutical drug pricing controversy, in his case EpiPens, that affects many middle-classed Americans. By using the appeals of ethos, logos, and pathos, Baker presents a viewpoint that is antagonistic of the business practices pharmaceutical companies have been following for the last decade. One of the ways Baker acknowledges their argument is by appealing to the emotion of his audience with his introductory sentence that shows how parents are forced to make hard choices surrounding the health of their children. “All too often, parents of children with food allergies are forced to make hard choices. Many are splitting up twin packs of EpiPens, others are keeping them past their expiration dates, delaying filling the prescription,
EpiPen With the recent price increase for the life saving EpiPen many families are being forced to either pay the absurd amount for the drug or to risk their safety and go without one. This imperative device is a prefilled syringe that inject a small dosage of epinephrine into the thigh muscle which suppresses the immune system to open up the airways closed off by fatal allergic reactions such as bee stings or nuts. For 43 Billion people across Americans the EpiPen is a necessity to daily life. One that which many people now are deciding to go without.
The Pure Food and Drug Act of 1906, which we have already discussed, was the primary reason the Food and Drug Administration (FDA) was established. This law was created because many people relocated to cities to work in factories and other urban jobs, and because there was little to no workplace or product safety, pre-made goods were required because city dwellers could not produce them themselves. The Food and Drug Administration is responsible for a wide range of duties, including dietary supplements, bottled water, food additives, infant formulas, prescription drugs, non prescription drugs, vaccines for humans, blood and blood products, cellular and gene therapy products, tissue and tissue products, allergenics, heart pacemakers, dental devices, surgical implants and prosthetics, x-ray equipment, ultrasonic therapy equipment, color additives found in makeup and other personal care products, skin moisturizers and cleansers, nail polish and perfume, livestock feeds, pet foods, veterinary drugs and devices, cigarettes, e-cigarettes, and
Chris McCandless, whose story is analyzed in Into the Wild, by Jon Krakauer, is a young adult who decides to leave his known habits and material belongings behind and live a completely self-sufficient life in the wilderness, a choice which ultimately leads to his death. In doing that, he also forfeits his family and friends. With that in mind, a question can be posed regarding the ethics of said behavior. As a childless, single and financially independent man, Chris McCandless has absolute ownership of his body and thus his decision to continue doing a sport that he knows can kill him is ethically defensible.
Planning is transforming socially, but to achieve change it has to bring together, politicians, planners, and residents (Sandercock, 2004). Citizen’s opinions and rights should be taken into consideration. It is the number one rule in the planning process for participants. It says, “recognize the rights of citizens to participate in planning decisions” (Ethical, n.d.). Cities cannot progress unless they change their ways of doing things.
Abstract The term ethical standard is used by substance abuse counselor that define the meaning of ethics of ethical. First, the meaning of ethical is “pertaining to or dealing with morals or the principles of morality.” (n.d., Dictionary.com Unabridged) Besides, the code of ethics in any profession whether it’s counseling, business field, medicine, or even law was created to establish guidelines for the professionals to abide by.
In the UK, policies for health, safety and security are not only give positive impact it also creates dilemma in relation to implement. Dilemma refers to a situation in which a difficult choice has to he made between two or more alternatives, especially equally undesirable ones. There are different types of dilemma in safety. This includes * Resource implications
One of those most challenging areas I have experience during my current placement is ethical decision-making. We studied many possible scenarios during our Values, Ethics and Professional Issues class, and discussed the various types of decision-making models to help guide us when having to make difficult decisions. While the class was invaluable, because it helped me identify my own biases, and also shed light on how I have made decisions in the past and how I can possibly make decisions in the future, I knew that having to make real-life decisions would not be so cut and dry. This placement has been challenging for me, because my ongoing assignment with one of my supervisors requires constant ethical decision-making, sometimes even in the
Ethical decision-making process are influenced by both individual and environmental characteristics, as well as an interaction with the cognitive process (Cooper, 2012). For every public official whose loyalty is to himself, his organization, and the public, the ethical decision-making process is dynamic, it is not constant, it involves a process of recognizing the problem and moving through the course of action towards finding a possible solution. It is contingent upon several factors. There is no one-size-fits-all for every situation, but the course of action is determined by the individual and environmental factors involved and the ethical character the public official has built over time. Ethical Decision Making